Aardvark Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| DECHENG CAPITAL LLC | 02/12/2026 | 3.92 M | $51.41 M | 0.00% | 18.04% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.29 M | $16.92 M | -5.19% | 5.94% |
| LAURION CAPITAL MANAGEMENT LP | 02/17/2026 | 1.01 M | $13.32 M | -3.32% | 4.67% |
| BLACKROCK, INC. | 02/12/2026 | 784.43 K | $10.30 M | 153.48% | 3.61% |
| VANGUARD GROUP INC | 01/29/2026 | 717.43 K | $9.42 M | 29.10% | 3.30% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 483.34 K | $6.34 M | 51.22% | 2.23% |
| 02/12/2026 | 476.60 K | $6.26 B | 100.00% | 2.19% | |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 303.94 K | $3.99 M | -0.97% | 1.40% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 297.87 K | $3.91 M | 53.51% | 1.37% |
| STATE STREET CORP | 02/13/2026 | 158.24 K | $2.08 M | 70.14% | 0.73% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 128.79 K | $1.69 M | 102.59% | 0.59% |
| CENTIVA CAPITAL, LP | 02/13/2026 | 97.52 K | $1.28 M | 100.00% | 0.45% |
| CANTOR FITZGERALD, L. P. | 02/17/2026 | 91.68 K | $1.20 M | -5.17% | 0.42% |
| NORTHERN TRUST CORP | 02/17/2026 | 89.30 K | $1.17 M | 56.12% | 0.41% |
| MORGAN STANLEY | 02/13/2026 | 77.95 K | $1.02 M | 13.86% | 0.36% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/17/2026 | 69.50 K | $912.14 K | 100.00% | 0.32% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 53.35 K | $700.21 K | 181.87% | 0.25% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/17/2026 | 50.13 K | $657.97 K | -80.24% | 0.23% |
| PROPEL BIO MANAGEMENT, LLC | 02/11/2026 | 46.41 K | $609.11 K | 100.00% | 0.21% |
| NUVEEN, LLC | 02/12/2026 | 41.02 K | $538.41 K | 100.00% | 0.19% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 36.92 K | $484.60 K | 100.00% | 0.17% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 35.92 K | $472.00 K | 100.00% | 0.17% |
| JUMP FINANCIAL, LLC | 02/17/2026 | 34.58 K | $453.80 K | 100.00% | 0.16% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 31.53 K | $413.87 K | 121.44% | 0.15% |
| HRT FINANCIAL LP | 02/12/2026 | 31.07 K | $407.00 K | 100.00% | 0.14% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 30.66 K | $402.41 K | 28.12% | 0.14% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 27.00 K | $354.38 K | 22.73% | 0.12% |
| UBS GROUP AG | 01/29/2026 | 26.84 K | $352.25 K | -50.96% | 0.12% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 26.20 K | $343.88 K | 1.95% | 0.12% |
| XTX TOPCO LTD | 02/17/2026 | 25.55 K | $335.32 K | 100.00% | 0.12% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 22.42 K | $294.20 K | 44.40% | 0.10% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 02/11/2026 | 20.84 K | $217.95 K | 100.00% | 0.10% |
| BARCLAYS PLC | 02/13/2026 | 20.52 K | $269.27 K | -48.61% | 0.09% |
| DIAMETRIC CAPITAL, LP | 02/13/2026 | 19.31 K | $253.43 K | 100.00% | 0.09% |
| ALPS ADVISORS INC | 02/12/2026 | 17.88 K | $234.64 K | 100.00% | 0.08% |
| TREXQUANT INVESTMENT LP | 02/17/2026 | 16.84 K | $221.08 K | 100.00% | 0.08% |
| WALLEYE CAPITAL LLC | 02/13/2026 | 16.05 K | $210.63 K | 100.00% | 0.07% |
| DIADEMA PARTNERS LP | 02/17/2026 | 15.88 K | $208.45 K | 100.00% | 0.07% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 15.86 K | $208.11 K | -71.96% | 0.07% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 14.08 K | $184.80 K | 259.46% | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 13.82 K | $181.35 K | 100.00% | 0.06% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 02/12/2026 | 7.75 K | $101.72 K | 100.00% | 0.04% |
| RHUMBLINE ADVISERS | 02/13/2026 | 7.55 K | $99.14 K | 32.41% | 0.03% |
| JPMORGAN CHASE & CO | 02/11/2026 | 6.88 K | $90.34 K | 197.19% | 0.03% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 6.39 K | $83.85 K | 11.55% | 0.03% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/17/2026 | 5.93 K | $77.82 K | 129.36% | 0.03% |
| PERSISTENT ASSET PARTNERS LTD | 02/17/2026 | 4.23 K | $55.53 K | 100.00% | 0.02% |
| NEW YORK STATE COMMON RETIREMENT FUND | 02/12/2026 | 3.82 K | $50.18 K | 0.00% | 0.02% |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 01/29/2026 | 3.55 K | $46.57 K | 100.00% | 0.02% |
| POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 02/13/2026 | 2.12 K | $27.83 K | 0.00% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aardvark Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 66 institutional investors and hedge funds held shares of Aardvark Therapeutics Inc.. The most heavily invested institutionals were:
Decheng Capital LLC: 3.92 M
CITADEL ADVISORS LLC: 1.29 M
BlackRock, Inc.: 784,430
VANGUARD GROUP INC: 717,430
MILLENNIUM MANAGEMENT LLC: 483,340
SILVERARC CAPITAL MANAGEMENT, LLC: 303,939
38.24% of Aardvark Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 9.17 M shares in the last 24 months. This purchase volume represents approximately $112.94 M in transactions.